Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap

about

Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap

Item

http://www.wikidata.org/entity/Q58806313

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap

@en

Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap

@nl

type

Item

label

Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap

@en

Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap

@nl

prefLabel

Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap

@en

Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap

@nl

P1476

Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap

@en

P2093

Danming You

http://www.w3.org/2001/XMLSchema#string

Jiaqi Ye

http://www.w3.org/2001/XMLSchema#string

Liyu Fan

http://www.w3.org/2001/XMLSchema#string

Sihan Liu

http://www.w3.org/2001/XMLSchema#string

Xiaoli Zhang

http://www.w3.org/2001/XMLSchema#string

Xin Chen

http://www.w3.org/2001/XMLSchema#string

Xinjie Xu

http://www.w3.org/2001/XMLSchema#string

Yuqing Chen

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease

Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma.

Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD).

Clinical characteristics of asthma combined with COPD feature

Proportional classifications of COPD phenotypes.

Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies

Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD.

The clinical features of the overlap between COPD and asthma.

Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.

Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects

P304

2371-2379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/DDDT.S165161

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peng Luo

Junsheng Fan

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30122895

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

mechanism of action

asthma

hydrocarbon

P932

6078181

http://www.w3.org/2001/XMLSchema#string